Theranostic Terbium Radioisotopes: Challenges in Production for Clinical Application

Currently, research on terbium has gained a momentum owing to its four short-lived radioisotopes, 149Tb, 152Tb, 155Tb, and 161Tb, all of which can be considered in one or another field of nuclear medicine. The members of this emerging quadruplet family have appealing nuclear characteristics and have the potential to do justice to the proposed theory of theranostics nuclear medicine, which amalgamates therapeutic and diagnostic radioisotopes together. The main challenge for in vivo use of these radioisotopes is to produce them in sufficient quantity. This review discusses that, at present, neither light charged particle nor the heavy ion (HI) activation are suitable for large-scale production of neutron deficient terbium nuclides. Three technological factors like (i) enrichment of stable isotopes to a considerable level, (ii) non-availability of higher energies in commercial cyclotrons, and (iii) non-availability of the isotope separation technique coupled with commercial accelerators limit the large scale production of terbium radionuclides by light charged particle activation. If in future, the technology can overcome these hurdles, then the light charged particle activation of enriched targets would produce a high amount of useful terbium radionuclides. On the other hand, to date, the spallation reaction coupled with an online isotope separator has been found suitable for such a requirement, which has been adopted by the CERN MEDICIS programme. The therapeutic 161Tb radionuclide can be produced in a reactor by neutron bombardment on enriched 160Gd target to produce 161Gd which subsequently decays to 161Tb. The radiochemical separation is mandatory even if the ISOL technique is used to obtain high radioisotopic purity of the desired radioisotope.

Opportunities for detailed fission studies using light charged particle reactions

Since its discovery in 1939, the nuclear fission process has provided much insight into the behavior of nuclei under many different conditions. As part of the nuclear chain reaction, the fission process has had a profound impact on modern society and it has consequently attracted much attention to the field of nuclear physics. In this talk, I will argue that the time is ripe for a resumption of studies of the fission process induced by light charged particle reactions. Although fission can be induced in heavy nuclei by several means, in some cases these methods suffer from the complication that fission can occur at several points during the decay chain thus mixing up contributions from different excitation energies. Using instead light charged particle reactions to excite the nuclei in question, the precise excitation energy from which fission takes place, can be determined. In fact, a number of such studies were carried out previously, and a first set of results on fission barrier heights, mass, energy and angular distributions were obtained. Applying detection techniques developed over the last decades will allow researchers to obtain detailed, high-quality data from which to probe and refine our present understanding of the process. Based on these observations, I suggest that substantial advances in the study of this process can be achieved by using simple light charged particle reactions.